Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure

Warren H. Chan, Daniel J. Lewis, Esther J. Kim, Phyu P. Aung, Madeleine Duvic

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Generalized morphea is associated with epoxy resin vapors and is characterized by the development of lesions shortly after exposure. Morphea presenting along with eosinophilic fasciitis (EF), or morphea/EF overlap, is rare and an indicator of poor prognosis and resistance to treatment. Here we present a case of generalized morphea/EF overlap linked to epoxy exposure. Our patient received multiple therapies—ultraviolet A1 phototherapy, prednisone, methotrexate, azathioprine, mycophenolate mofetil, cyclophosphamide, cyclosporine, and rituximab—none of which led to a significant response. The refractory nature of this disease warrants vigilance in its association with epoxy exposure.

Original languageEnglish (US)
Pages (from-to)175-178
Number of pages4
JournalJAAD Case Reports
Volume4
Issue number2
DOIs
StatePublished - Mar 1 2018

Keywords

  • azathioprine
  • eosinophilic fasciitis
  • epoxy
  • generalized morphea
  • phototherapy
  • ultraviolet A1

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure'. Together they form a unique fingerprint.

Cite this